Nanexa AB

May 8, the Swedish market closes at 1 p.m., the markets in Denmark and Norway are open as usual. May 9 all markets are closed.

Nanexa is a nanotechnology company. The main business is focused on Drug-Delivery where the company has developed a technological platform that is used to improve conditions in pharmaceutical formulations and in the release of various medicines. Additionally, the company provides antifungal coating and low friction surface for peripheral venous catheters. The company was established in 2006 and is based in Uppsala.

Quotes for Nanexa AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • David Westberg

Chairperson of the Board

  • Hans Arwidsson

Board

  • Anders Johansson
  • Bengt Gustavsson
  • Magnus Westgren
  • Otto Skolling
  • Urban Paulsson
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Aktiekvällen Stockholm 21 januari - Nanexa

    Nanexa - Life Science-dagen 2018

    Stora Aktiedagen Stockholm – Nanexa

    Intervju med Finwire

    Largest Owners

    Name Capital % Votes % Date
    Novo Nordisk A/S 19,90 19,90 2024-04-26
    Nordnet Pensionsförsäkring 5,30 5,30 2024-04-26
    Avanza Pension 5,27 5,27 2024-04-26
    Applied Ventures, LLC 5,16 5,16 2024-04-26
    Rutger Arnhult 3,07 3,07 2024-04-26
    Jan Petersen 2,61 2,61 2024-04-26
    Mikael Jacobsson 2,42 2,42 2024-04-26
    Erik Hedlund 2,21 2,21 2024-04-26
    Gunvald Berger 1,92 1,92 2024-04-26
    Ivar Nordqvist 1,72 1,72 2024-04-26

    Annual reports, prospectus etc.